Ignite Creation Date:
2025-12-25 @ 12:17 AM
Ignite Modification Date:
2026-02-23 @ 3:01 PM
Study NCT ID:
NCT00814658
Status:
COMPLETED
Last Update Posted:
2013-08-26
First Post:
2008-12-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life
Sponsor:
Janssen-Cilag Farmaceutica Ltda.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR014938
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None